Author

Carsten Schmidt 1

1 Fulda Hospital,Fulda,Germany

COMPARATIVE EFFICACY AND SAFETY OF ORAL FERRIC MALTOL IN INFLAMMATORY BOWEL DISEASE PATIENTS WITH MILD-TO-MODERATE VS. MORE SEVERE IRON DEFICIENCY ANAEMIA

Stefanie Howaldt, Ian Jacob, Carsten Schmidt, Fatma Akriche

European Crohn’s and Colitis Organisation Topical Review on IBD in the Elderly

Andreas Sturm, Christian Maaser, Michael Mendall, Dimitrios Karagiannis, Pantelis Karatzas, Nienke Ipenburg, Shaji Sebastian, Fernando Rizzello, Jimmy K. Limdi, Konstantinos H. Katsanos, Carsten Schmidt, Steven Jeuring, Francesco Colombo, Paolo Gionchetti

LONG-TERM TREATMENT WITH FERRIC MALTOL IS EFFECTIVE AND WELL TOLERATED IN CORRECTING IRON DEFICIENCY ANEMIA IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE: RESULTS FROM A PHASE-3 OPEN-LABEL STUDY

Carsten Schmidt

LONG-TERM TREATMENT WITH FERRIC MALTOL IS EFFECTIVE AND WELL TOLERATED IN CORRECTING IRON DEFICIENCY ANEMIA IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE: RESULTS FROM A PHASE-3 OPEN-LABEL STUDY

Carsten Schmidt, Tariq Ahmad, Zsolt Tulassay, Daniel C. Baumgart, Bernd Bokemeyer, Stefanie Howaldt, Andreas Stallmach, Carsten Büning

MUCOSAL PHOSPHTIDYLCHOLINE AND LYSOPHOSPHATIDYLCHOLINE CONCENTRATIONS ARE REDUCED IN SEPSIS INDUCED MUCOSAL BARRIER DYSFUNCTION

Carsten Schmidt, Christian Lautenschläger, Annika Gauss, Otmar Huber, Wolfgang Stremmel, Andreas Stallmach

TNF-ALPHA AS INDUCTION AND MAINTENANCE THERAPY FOR CROHN´S DISEASE: A PROSPECTIVE OBSERVATIONAL STUDY IN GERMANY

Bernd Bokemeyer, Ulf Helwig, Carsten Schmidt, Thomas Krummenerl, Ann-Katrin Rupf, Heinz Hartmann, Anette Krummenerl, Marc Düffelmeyer, Regina Hinrichs, Petra Hartmann, Susanna Nikolaus, Dietrich Hüppe, Stefan Schreiber

VEDOLIZUMAB FOR INFLAMMATORY BOWEL DISEASE IN CLINICAL PRACTICE – EXPERIENCE FROM A PROSPECTIVE GERMAN REGISTRY

Daniel C. Baumgart, Raja Atreya, Oliver Bachmann, Michael Bläker, Bernd Bokemeyer, Norbert Börner, Jürgen Büning, Axel Dignass, Atylla Drabik, Robert Ehehalt, Andreas Fischer, Franz Hartmann, Heinz Hartmann, Stefanie Howaldt, Petra Jessen, Thomas Krummenerl, Tanja Kuehbacher, Andreas Luegering, Jochen Maul, Michael Mross

VEDOLIZUMAB PROVIDES CLINICAL BENEFIT OVER ONE YEAR IN PATIENTS WITH REFRACTORY INFLAMMATORY BOWEL DISEASE - RESULTS OF A PROSPECTIVE MULTICENTER OBSERVATIONAL STUDY

Raja Atreya, Daniel C. Baumgart, Tony Bruns, Axel Dignass, Katrin Ende, Jochen Hampe, Franz Hartmann, Christian Langbein, Jochen Maul, Markus F. Neurath, Jan C. Preiss, Renate Schmelz, Carsten Schmidt, Hermann Schulze, Britta Siegmund, Niels Teich, Ulrike von Arnim, Andreas Stallmach

Item 1 - 8 / 14
1
2